Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Reimbursement Drops to AWP-15% Under Senate Tax Bill

Executive Summary

The Senate tax bill would cut Medicare Part B reimbursement for drugs to 85% of AWP

You may also be interested in...



Senate AWP Plan Directs HHS To Determine “Market Price” For Chemotherapy

The Senate Finance Committee's Medicare reform bill includes a provision directing HHS to determine actual "market prices" for reimbursement of outpatient drugs currently covered under part B

Senate AWP Plan Directs HHS To Determine “Market Price” For Chemotherapy

The Senate Finance Committee's Medicare reform bill includes a provision directing HHS to determine actual "market prices" for reimbursement of outpatient drugs currently covered under part B

Medicare Rx Ready For Committee; Length Of PBM Contracts Is One Issue

The Bush Administration would be open to a Medicare drug benefit that involves long-term contracts with health plans to reduce volatility in the system, CMS Administrator Tom Scully indicated during a Senate Finance Committee hearing June 6

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel